Vigil Neuroscience, Inc.
VIGLDelisted Aug 5, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001827087
Vigil Neuroscience, Inc. was delisted on Aug 5, 2025; its insiders filed their last Form 4 on Aug 7, 2025; 78 institutions reported holding it in 13F filings for Q2 2025, worth $265.8M in total; no superinvestor held it.
13F holders, Q4 2023
Institutional positions in Vigil Neuroscience, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 46
- +1 vs. Q3 2023
- Shares held
- 25.0M
- −581.0K (−2.3%) vs. Q3 2023
- Total value
- $84.4M
- −$53.3M (−38.7%) vs. Q3 2023
- New holders
- 7
- 15 more added
- Sold out
- 6
- 12 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VIGL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 2 | $4.55K |
| Q2 2025 | 78 | $265.8M |
| Q1 2025 | 50 | $44.5M |
| Q4 2024 | 51 | $38.4M |
| Q3 2024 | 52 | $94.2M |
| Q2 2024 | 58 | $104.5M |
| Q1 2024 | 54 | $90.5M |
| Q4 2023 | 46 | $84.4M |
| Q3 2023 | 45 | $137.7M |
| Q2 2023 | 47 | $242.1M |
| Q1 2023 | 41 | $245.4M |
| Q4 2022 | 37 | $312.3M |
| Q3 2022 | 33 | $222.7M |
| Q2 2022 | 35 | $44.6M |
| Q1 2022 | 47 | $125.1M |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Vigil Neuroscience, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 5,836,874 | $19.7M | 2.35% | 00.0% | Unchanged |
| Northpond Ventures, LLC | 4,214,498 | $14.2M | 67.78% | 00.0% | Unchanged |
| Citadel Advisors LLC | 2,161,902 | $7.31M | 0.01% | −4,211−0.2% | Reduced |
| BVF Inc | 1,813,633 | $6.13M | 0.15% | 00.0% | Unchanged |
| Artal Group S.A. | 1,811,191 | $6.12M | 0.21% | −96,944−5.1% | Reduced |
| Deep Track Capital, LP | 1,594,931 | $5.39M | 0.19% | −172,200−9.7% | Reduced |
| Deerfield Management Company, L.P. (Series C) | 1,173,523 | $3.97M | 0.07% | −653,877−35.8% | Reduced |
| BlackRock Inc. | 919,132 | $3.11M | 0.00% | +71,853+8.5% | Added |
| Vanguard Group Inc | 799,197 | $2.70M | 0.00% | +5,231+0.7% | Added |
| Pivotal bioVenture Partners Investment Advisor LLC | 560,595 | $1.89M | 0.48% | 00.0% | Unchanged |
| Sphera Funds Management Ltd. | 535,120 | $1.81M | 0.34% | +535,120 | New |
| Rock Springs Capital Management LP | 471,958 | $1.60M | 0.04% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 448,891 | $1.52M | 0.03% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 315,538 | $1.07M | 0.00% | +10,363+3.4% | Added |
| ArrowMark Colorado Holdings LLC | 289,460 | $978.4K | 0.01% | +289,460 | New |
| State Street Corp | 283,291 | $957.5K | 0.00% | +5,678+2.0% | Added |
| Ensign Peak Advisors, Inc | 228,674 | $772.9K | 0.00% | +216,750+1,817.8% | Added |
| Anson Funds Management LP | 207,016 | $699.7K | 0.14% | +207,016 | New |
| Trustees of Columbia University in the City of New York | 192,973 | $652.2K | 1.38% | 00.0% | Unchanged |
| Northern Trust Corp | 141,401 | $477.9K | 0.00% | +15,667+12.5% | Added |
| FMR LLC | 140,834 | $476.0K | 0.00% | −248−0.2% | Reduced |
| Bridgeway Capital Management, LLC | 132,964 | $449.4K | 0.01% | +132,964 | New |
| Barclays PLC | 123,795 | $418.4K | 0.00% | +19,205+18.4% | Added |
| Goldman Sachs Group Inc | 85,100 | $287.6K | 0.00% | −61,102−41.8% | Reduced |
| DAFNA Capital Management LLC | 71,815 | $242.7K | 0.06% | −100,493−58.3% | Reduced |
| Citigroup Inc | 66,652 | $225.3K | 0.00% | +2,349+3.7% | Added |
| Morgan Stanley | 54,914 | $185.6K | 0.00% | +42,555+344.3% | Added |
| Bank of New York Mellon Corp | 48,488 | $163.9K | 0.00% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 41,968 | $141.9K | 0.00% | 00.0% | Unchanged |
| PEAK6 Investments LLC | 41,486 | $140.2K | 0.01% | +17,690+74.3% | Added |
| Bank of America Corp | 29,034 | $98.1K | 0.00% | +5,433+23.0% | Added |
| Nuveen Asset Management, LLC | 26,840 | $90.7K | 0.00% | +2,125+8.6% | Added |
| Rhumbline Advisers | 17,269 | $58.4K | 0.00% | −779−4.3% | Reduced |
| Two Sigma Investments, LP | 15,728 | $53.2K | 0.00% | +15,728 | New |
| JPMorgan Chase & Co | 10,415 | $35.2K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 10,178 | $34.4K | 0.00% | +10,178 | New |
| New York State Common Retirement Fund | 10,140 | $34.3K | 0.00% | −25−0.2% | Reduced |
| STRS Ohio | 8,200 | $27.0K | 0.00% | +8,200 | New |
| American International Group, Inc. | 7,987 | $27.0K | 0.00% | −32−0.4% | Reduced |
| Wells Fargo & Company | 4,926 | $16.6K | 0.00% | +974+24.6% | Added |
| Royal Bank of Canada | 4,287 | $15.0K | 0.00% | +468+12.3% | Added |
| Tower Research Capital LLC (TRC) | 2,883 | $9.74K | 0.00% | +532+22.6% | Added |
| California State Teachers Retirement System | 2,645 | $8.94K | 0.00% | −901−25.4% | Reduced |
| Legal & General Group Plc | 1,554 | $5.27K | 0.00% | 00.0% | Unchanged |
| Amalgamated Bank | 1,402 | $5.00K | 0.00% | −161−10.3% | Reduced |
| Ameritas Investment Partners, Inc. | 1,327 | $4.49K | 0.00% | 00.0% | Unchanged |
| Cormorant Asset Management, LP | 0 | $0 | 0.00% | −616,786−100.0% | Sold out |
| Harvard Management Co Inc | 0 | $0 | 0.00% | −289,460−100.0% | Sold out |
| Logos Global Management LP | 0 | $0 | 0.00% | −188,390−100.0% | Sold out |
| Laurion Capital Management LP | 0 | $0 | 0.00% | −10,839−100.0% | Sold out |
| Nisa Investment Advisors, LLC | 0 | $0 | 0.00% | −30−100.0% | Sold out |
| Coppell Advisory Solutions LLC | 0 | $0 | 0.00% | −34−100.0% | Sold out |